BSET
Bassett Furniture Industries, Incorporated
BSET has lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has a slight edge over BSET overall, supported by stronger valuation and stronger fundamentals.
BSET Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
BSET's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BSET PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.7x | $2.16 | -90% |
| Fair | 10x | $8.25 | -62% |
| Forward | 19x | $21.59 | — |
| Current | 27x | $21.59 | — |
| Expensive | 28x | $21.83 | +1.1% |
Historical ranges are pointers, not guarantees.
BSET's PE is in its expensive range at 27x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its fair range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BSET Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect BSET's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BSET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.15 | +46% |
| Q3 2026 | $0.79 | -11% |
| Q2 2026 | $0.64 | +129% |
| Q1 2026 | $0.62 | +$1.38 |
| Q4 2025 | $0.70 | +$1.81 |
| Q3 2025 | $0.89 | +$2.83 |
| Q2 2025 | $0.28 | +$2.00 |
| Q1 2025 | -$0.76 | -$0.10 |
| Q4 2024 | -$1.11 | -$0.75 |
BSET has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BSET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.8M | +3.4% |
| Q2 2026 | $83.8M | -0.7% |
| Q1 2026 | $80.3M | -2.2% |
| Q4 2025 | $88.7M | +5.1% |
| Q3 2025 | $80.1M | +5.9% |
| Q2 2025 | $84.3M | +1.1% |
| Q1 2025 | $82.2M | -5.1% |
| Q4 2024 | $84.3M | -11% |
BSET's revenue fell from its 2021 peak and has held roughly level since: $83M last quarter, up 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.4% | +2.6 points |
| Q2 2026 | 2.7% | -0.3 points |
| Q1 2026 | 1.4% | -1.6 points |
| Q4 2025 | 2.6% | +1.5 points |
| Q3 2025 | 0.7% | +9.2 points |
| Q2 2025 | 3% | +13 points |
| Q1 2025 | 3% | +5.7 points |
| Q4 2024 | 1.1% | +5.8 points |
BSET has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BSET on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BSET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.8M | +$4.5M |
| Q2 2026 | $5.6M | +1.5% |
| Q1 2026 | -$6.3M | -$5.4M |
| Q4 2025 | $7M | +19% |
| Q3 2025 | -$2.6M | -$1.2M |
| Q2 2025 | $5.6M | +32% |
| Q1 2025 | -$923K | +$8.9M |
| Q4 2024 | $5.9M | +4.2% |
BSET has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BSET Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +2.8K shares |
| 1 year | -0.4% | -36.1K shares |
| 3 years | -1.1% | -97K shares |
| 5 years | -12% | -1.1M shares |
| Available history | -16% | -1.6M shares |
BSET has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $126,000 |
| Q2 2026 | $506,000 |
| Q1 2026 | $147,000 |
| Q4 2025 | $628,000 |
| Q3 2025 | $364,000 |
| Q2 2025 | $437,000 |
| Q1 2025 | $721,000 |
| Q4 2024 | $293,000 |
BSET spent $1M buying back its own shares over the past year, down 22% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BSET Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.0x | Net Cash |
| Q2 2026 | -2.4x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.5x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -4.6x | Net Cash |
| Q1 2024 | -17.9x | Net Cash |
| Q4 2023 | -7.5x | Net Cash |
BSET has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BSET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.9 | Neutral |
| Stochastic | 78.5 | Neutral |
BSET's weekly RSI is 63 (neutral) and its Stochastic is 79 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BSET PE vs Consumer Cyclical Sector
| Metric | BSET | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 18x | 52% above |
| PE % | 82 | 47 | 35 pts above |
BSET is trading at 27x earnings, a 52% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BSET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 2% above |
| 20 week MA | $20.1 | 7.4% above |
| 50 week MA | $17.3 | 25% above |
| 100 week MA | $16.5 | 31% above |
| 200 week MA | $15.9 | 36% above |
BSET has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BSET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.8 | $19.9 | +18% |
| 2021 | $19.9 | $16.6 | -17% |
| 2022 | $16.6 | $17.1 | +3.1% |
| 2023 | $17.1 | $16.6 | -2.8% |
| 2024 | $16.6 | $13.9 | -17% |
| 2025 | $13.9 | $17.1 | +24% |
| 2026 YTD | $17.1 | $21.6 | +26% |
BSET has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.